Deferoxamine
Active substance: deferoxamine
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DEFEROXAMINE MESYLATE 95 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEFEROXAMINE MESYLATE · 95 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-a405-75a4-bed6-9ec955025117,01a12090-09ba-78c2-b8e2-53144d42e87d,01a12092-02aa-744d-8def-1ee3ffe442ff,01a12092-5e75-788b-b8bc-aec68ae109ce,01a12093-3f7b-74fe-8168-96cc69ec28b3;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63323-599
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sources
- product · openFDA NDC · 63323-599 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-599 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-599 · Verified 2026-10-09 · open in source